Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  London Stock Exchange  >  GlobalData Plc    DATA   GB00B87ZTG26

GLOBALDATA PLC

(DATA)
  Report  
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsOfficial PublicationsSector news

GlobalData : Andhra Pradesh and Telangana are manufacturing powerhouses for US API supply

share with twitter share with LinkedIn share with facebook
share via e-mail
0
10/07/2019 | 08:42am EDT
07 Oct 2019
Andhra Pradesh and Telangana are manufacturing powerhouses for US API supply
Posted in Healthcare, Press Release

The Indian state of Telangana is renowned as a hub for the country's pharmaceutical industry, accounting for 35-40% of national pharma production, and its position will strengthen with the completion of Hyderabad Pharma City, which is currently under construction. Telangana and Andhra Pradesh, both of which are central-south states, have the most pharma CMO manufacturing out of all Indian states, according to GlobalData, a leading data and analytics company.

Telangana has more than double the amount of European Medicines Agency (EMA) and/or Food and Drug (FDA)-approved pharmaceutical facilities as Andhra Pradesh, at 173 facilities and 75 facilities, respectively. Major pharma companies and CMOs such as Mylan NV, Albany Molecular Research Inc, and Cambrex Corp have manufacturing facilities in Telangana.

Adam Bradbury, Pharma Analyst at GlobalData, commented: 'Half of this state's pharma manufacturing facilities are involved in API manufacture. Most facilities in Andhra Pradesh and Telangana are owned by domestic Indian pharmaceutical companies. In line with the global perception of a strong generics manufacturing industry in India, the majority of these regions' facilities offer small molecule API manufacturing.

'Unlike other Indian states covered in previous EMOR articles, there is an unusually high number of CMOs with multiple facilities in Andhra Pradesh and Telangana. This may be attributable to larger CMOs being headquartered in these states and heavily investing in the region. Nonetheless, the majority of facilities (62%) belong to companies with a single site in the region, which indicates the large merger and acquisition (M&A) potential of the Indian industry as the value of the market increases.'

One company, Aurobindo Pharma Ltd has 17 facilities in the region. The company markets a wide range of its own drugs and provides contract services for generic drugs and Active Pharmaceutical Ingredients (APIs). It has five facilities in Andhra Pradesh and 12 in Telangana, roughly equivalent to the overall facilities split in the region. It has only two facilities located outside the region, in the US and Rajasthan, India.

Disclaimer

GlobalData plc published this content on 07 October 2019 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 07 October 2019 12:41:07 UTC

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on GLOBALDATA PLC
10/10GLOBALDATA : Luminal unfolding microneedle injector to improve treatment options..
PU
10/10GLOBALDATA : India leads with 18% of global LNG regasification capacity addition..
PU
10/10GLOBALDATA : 3D printing promises enhanced operational efficiency and business g..
PU
10/10GLOBALDATA : Inbound health and wellness tourism to China set to double by 2022,..
PU
10/10GLOBALDATA : India's mobile service revenues set to reach US$39.8bn in 2024, say..
PU
10/10GLOBALDATA : The Middle East set to propel global acetic acid capacity additions..
PU
10/10GLOBALDATA : PepsiCo partners with HUEMN to foray into fashion industry in India..
PU
10/09GLOBALDATA : Renault-Nissan Alliance needs re-set, says GlobalData
PU
10/09GLOBALDATA : Hays Travel acquiring Thomas Cook stores is a gamble that could pay..
PU
10/09GLOBALDATA : Government focuses on road and rail projects as construction indust..
PU
More news
Financials (GBP)
Sales 2019 177 M
EBIT 2019 40,1 M
Net income 2019 15,0 M
Debt 2019 50,1 M
Yield 2019 1,63%
P/E ratio 2019 73,5x
P/E ratio 2020 46,1x
EV / Sales2019 5,82x
EV / Sales2020 5,42x
Capitalization 979 M
Chart GLOBALDATA PLC
Duration : Period :
GlobalData Plc Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends GLOBALDATA PLC
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 2
Average target price 920,00  GBp
Last Close Price 830,00  GBp
Spread / Highest target 10,8%
Spread / Average Target 10,8%
Spread / Lowest Target 10,8%
EPS Revisions
Managers
NameTitle
Michael Thomas Danson Chief Executive Officer & Director
Bernard Anthony Cragg Chairman
Graham Charles Lilley Chief Financial Officer, Secretary & Director
Peter Martin Harkness Independent Non-Executive Director
Murray Legg Non-Executive Director
Sector and Competitors
1st jan.Capitalization (M$)
GLOBALDATA PLC41.28%1 242
S&P GLOBAL INC.47.68%62 311
RELX13.61%45 061
THOMSON REUTERS CORPORATION35.20%33 580
WOLTERS KLUWER25.40%18 807
EQUIFAX INC.54.55%17 399